Redox Biology

Redox Biology is a premier open-access journal published by Elsevier, dedicated to the rapidly expanding field of redox biology in health and disease. With an ISSN of 2213-2317 and a 2026 Impact Factor of 16.200, the journal is consistently ranked in the JCR Q1 quartile, placing it among the top-tier publications in biochemistry, molecular biology, and cell biology. Its scope encompasses a broad spectrum of research, focusing on the roles of reactive oxygen species (ROS), reactive nitrogen species (RNS), and antioxidants in biological systems. Core topics include redox signaling, oxidative stress, cellular metabolism, mitochondrial function, ferroptosis, and the mechanistic links between redox processes and major human diseases such as cancer, cardiovascular disorders, neurodegeneration, diabetes, and aging. The journal welcomes original research articles, comprehensive reviews, and short communications that provide significant mechanistic insights or therapeutic perspectives. It also publishes special issues on emerging themes, including the interplay between redox biology and immunology or metabolism. The target audience is primarily academic and clinical researchers, postdoctoral fellows, and graduate students working in biochemistry, cell biology, pharmacology, and translational medicine. A defining feature of Redox Biology is its fully open-access model, ensuring that all published content is freely and permanently available to the global scientific community, which maximizes visibility and citation potential. Its exceptionally high Impact Factor and Q1 ranking underscore its status as a leading authority in the field, making it a preferred venue for groundbreaking studies that advance the fundamental understanding and clinical application of redox biology.